Herpes simplex virus type 1 (HSV-1) syncytial (syn) mutants cause formation of giant polykaryocytes and have been utilized to identify genes promoting or suppressing cell fusion. We previously described an HSV-1 recombinant, Fl (J. L. Goodman, M. L. Cook, F. Sederati, K. Izumi, and J. G. Stevens, J. Virol. 63:1153-1161, which has unique virulence properties and a syn mutation in the carboxy terminus of glycoprotein B (gB). We attempted to replace this single-base-pair syn mutation through cotransfection with a 379-bp PCR-generated fragment of wild-type gB. The nonsyncytial viruses isolated were shown by DNA sequencing not to have acquired the expected wild-type gB sequence. Instead, they had lost their cell-cell fusion properties because of alterations mapping to the UL45 gene. The mutant UL45 gene in one nonsyncytial derivative of Fl, A4B, was found to have a deletion of a C at UL45 nucleotide 230, resulting in a predicted frame shift and termination at 92 rather than 172 amino acids. Northern (RNA) analysis showed that the mutant UL45 gene was normally transcribed. However, Western immunoblotting showed no detectable UL45 gene product from A4B or from another similarly isolated nonsyncytial Fl derivative, A61B, while another such virus, IACSS, expressed reduced amounts of UL45. When A4B was cotransfected with the wild-type UL45 gene, restoration of UL45 expression correlated with restoration of syncytium formation. Conversely, cloned DNA fragments containing the mutant A4B UL45 gene transferred the loss of cell-cell fusion to other gB syn mutants, rendering them UL45 negative and nonsyncytial. We conclude that normal UL45 expression is required to allow cell fusion induced by gB syn mutants and that the nonessential UL45 protein may play an important role as a mediator of fusion events during HSV-1 infection.
One of the critical steps in the infection of cells with herpes simplex virus type 1 (HSV-1) is fusion between the viral envelope and the cell membrane, allowing penetration of the viral nucleocapsid into the cell. The mechanisms by which HSV-1 promotes membrane fusion are not well understood because of complex interactions of multiple viral and cellular proteins. Although HSV-1 lesions in vivo may show evidence of cell-cell fusion and polykaryocyte formation (43) , clinical isolates of HSV-1 normally do not maximally fuse cells in tissue culture. However, mutant viruses which have a greatly enhanced ability to fuse cells in vitro (syncytial or syn mutants) have been isolated and used to help identify the viral proteins involved in fusion in vivo. syn mutations have been mapped to at least the following four HSV-1 genes: UL27, which encodes glycoprotein B (gB) (4, 40) ; UL53, which encodes glycoprotein K (gK) (3, 21, 37); UL20, which encodes a membrane protein (2, 29) ; and UL24 (24, 41 ). An additional syn locus has been mapped to the HSV-1 long repeat region (39) .
The majority of mutations thus far characterized permit syncytium formation to occur, suggesting that expression of the respective wild-type proteins functions to modulate cell fusion (43) . The normal regulatory roles of two of these proteins, gB and gK, are further supported by the fact that fusion induced by mutant gB or gK is inhibited by cells expressing the corresponding wild-type proteins (22) . In contrast, there are few reports of HSV-1 proteins that function as mediators of cell fusion, that is, cases in which the wild-type protein is required to allow expression of the syncytial phenotype to occur (43) . gB (also a modulator) and glycoprotein D are two HSV-1 proteins which have been suggested to serve as mediators of cell fusion (5, 28, 36) , and by inference, these proteins could be critical to the virion-cell fusion process in vivo. Indeed, gB and glycoprotein D are both required for viral penetration and infectivity (5, 28) and gB is important in the spread of virus from one cell or tissue type to another (8, 14, 35) . In addition, variations in these proteins among clinical and laboratory isolates can profoundly affect viral pathogenicity and invasiveness (10, 14, 23, 48) .
In studies of HSV invasiveness which utilized inoculation of the chorioallantoic membrane (CAM) of fertilized chicken eggs (16, 34, 38) , we found that HSV-2 strains form large pocks, invade the CAM mesoderm, and kill embryos while HSV-1 strains normally form smaller pocks and do not kill (15) . We also reported that unlike other HSV-1 strains, syncytial strain ANG is virulent for chicken embryos and behaves like HSV-2 upon CAM inoculation (13) . We found that a syncytial recombinant virus, Fl, isolated from the progeny of the cotransfection of the cloned ANG EcoRI F fragment into wild-type virus 17syn+ had a millionfold increase in invasiveness in the CAM model and a thousandfold increase in neuroinvasiveness following footpad inoculation of mice (13) . To "797-bp HindIII-SphI fragments subcloned from the respective HSV-1 EcoRI I fragments (see Fig. 3 ).
3' end of the gB gene that alters a single amino acid in the C-terminal cytoplasmic domain of the protein (12, 14, 19) . This gB mutation, by itself, does not cause the CAM invasiveness phenotype, since we have isolated several recombinants containing this mutation which are not CAM invasive (20) . However, this same mutation, when introduced into 17syn+, dramatically alters disease pathogenesis and viral spread in mice (10, 14) . We therefore set out to evaluate whether this mutation at least contributes to the CAM invasiveness of Fl by rescuing it through cotransfection with sequences from the wild-type gB gene differing only with respect to the syncytial mutation.
As reported here, we isolated nonsyncytial derivatives of Fl from these initial experiments, but unexpectedly, all still carried the gB syn mutation present in Fl. We found that this phenotypic suppression of the gB syn mutation was due to a frameshift mutation mapping to the HSV-1 UL45 gene which has recently been characterized as a membrane protein by Visalli and Brandt (44) . We report the nucleotide sequence change involved and the ability of the mutated UL45 gene to be transferred to and cause loss of fusion induced by other HSV-1 strains with the same gB syn mutation. Conversely, restoration of wild-type UL45 gene expression to the UL45 mutants allowed full expression of the syncytial phenotype. From these studies, we conclude that the UL45 gene product is critical for full expression of the cell-cell fusion induced by HSV-1 gB syncytial mutants. We suggest that the UL45 gene product, the function(s) of which has not previously been described, is a mediator of cell fusion and may play an important role in cell-cell fusion processes.
MATERIALS AND METHODS
Cells and virus. Virus stocks were produced in rabbit skin (RS) cells maintained in Dulbecco's minimal essential medium supplemented with 5% fetal bovine serum as previously described (13, 15) . The stock virus strains used included reference strains 17syn+ and ANG (25) . The origin of 17syn+-ANG recombinant virus Fl has been previously described (13) . Other viruses isolated during this study are described in Results and listed in Tables 1 and 2 . Virus titers were determined by plating serial 10-fold dilutions of virus onto cells under medium supplemented with 0.3% human serum immune globulin. Plaque purifications were performed by three successive limiting dilutions onto RS cell monolayers in 96-well plates.
DNA isolation, molecular cloning, restriction, and hybridization analysis. Viral DNA was isolated either on sodium iodide gradients (46) or by a rapid miniprep method (10) . Plasmid DNAs were isolated either by cesium chloride density gradients as previously described (18) or by using Qiagen columns (Qiagen, Chatsworth, Calif.). Single-stranded M13 templates were purified on Qiagen columns. Restriction and modification enzymes were purchased from New England Biolabs (Beverly, Mass.), Boehringer Mannheim Biochemicals (Indianapolis, Ind.), or Gibco/BRL (Gaithersburg, Md.) and used in accordance with manufacturer specifications. Viral restriction fragments were either shotgun cloned or first purified from agarose gels by using the Qiaex glass matrix system (Qiagen) and then ligated into plasmids pUC18 and pUC19 or into M13mpl8 and mpl9 by standard methods (30, 32) . Plasmid constructs were transformed into Escherichia coli DH5a, and M13 clones were transformed into strain JM101 (30) . PCR fragments were cloned into the pCRII vector by using the TA cloning kit (Invitrogen, San Diego, Calif. (17) , as modified by Cai et al. (6) . Briefly, 0.5 to 1.0 ,ug of HSV-1 DNA and 10 ,ug salmon sperm carrier DNA (Sigma, St. Louis, Mo.) were allowed to precipitate with 0.1 to 1.0 ,ug of linearized cloned DNA or, where mentioned, uncloned HSV-1 fragments isolated from agarose gels. This mixture was then added to 60-mm-diameter petri dishes seeded 24 h earlier with RS cells such that the cells were just confluent at the time of transfection. Following 4 h of incubation at 37°C, the cells were shocked with 15% glycerol in Tricene-buffered salts for 2 min at room temperature and washed with phosphate-buffered saline (PBS). Finally, 5 ml of growth medium was added and the cells were incubated for 2 to 4 days, until a complete cytopathic effect was evident. Transfections were screened by inoculating appropriate dilutions of the transfections onto RS cell monolayers in six-well plates and then incubating them under an overlay medium containing 1% low-melting-point agarose (Seaplaque; FMC, Rockland, Maine). Frequencies of syncytial and nonsyncytial plaques were determined by visually screening the resultant viral plaques from each transfection. The frequencies presented should be considered approximate, since the methodology does not account for possible sibling viruses. Representative plaques were transferred to individual wells of a 24-well plate with sterile toothpicks. These viruses were then grown to a 100% cytopathic effect and then plaque purified by three rounds of limiting dilution.
Nucleotide sequencing. Nucleotide sequencing was done by the dideoxy-chain termination method (42) 24 -well plates in a volume of 0.1 ml at a multiplicity of infection of 0.1 or 10 PFU per cell and incubated for 1 h at 37°C. The inoculum was removed, and the wells were washed twice with 1 ml of PBS prior to addition of 1 ml of normal growth medium. At each time point studied, duplicate wells for each virus were freeze-thawed and individually assayed on RS cell monolayers by serial dilution under immune globulin as described above. Duplicate titrations of the duplicate wells were averaged to calculate the final titer.
RESULTS
Isolation of nonsyncytial derivatives of recombinant Fl. Strain 17syn+ recombinant strain Fl contains, at amino acid 825 near the 3' end of the gB gene, the syncytial mutation transferred from strain ANG (19) . We set out to specifically rescue this mutation in Fl with wild-type 17syn+ DNA, and as a control, we also sought to transfer the Fl syn mutation to the wild-type parent, 17syn+. To accomplish these objectives, we PCR amplified from both 17syn+ and Fl a 379-bp portion of the gB gene that contained the nucleotide residue altered in Fl (Fig. 1) . This fragment flanked the area in which the singlebase-pair syn mutation occurred in ANG and Fl but contained no other nucleotide differences between the strains (19) . The amplified product containing the wild-type gB-coding sequence from 17syn+ was cotransfected into RS cells with unit length DNA from Fl, and viral progeny were screened for wild-type (nonsyncytial) plaques. In simultaneous control transfections, the PCR product from Fl, containing the C-to-T nucleotide change responsible for the syn phenotype, was cotransfected with unit length 17syn' DNA and the progeny were screened for syncytial plaques.
We scored multiple transfections as to whether any progeny of the opposite phenotype were generated. From We plaque purified progeny viruses of the opposite phenotype from each of the transfections in which they were present. These progeny viruses and their respective derivations are listed in Table 1 .
Characterization of progeny viruses. The single-base-pair syn mutation in the ANG gB gene disrupts an NcoI restriction site (14) , allowing convenient screening for the gB syn mutation (Fig. 1) . To determine whether this mutation was acquired in the newly syncytial viruses (C4 series) derived from cotransfection of the Fl syn mutation into 17syn+ or, conversely, lost in the nonsyncytial viruses (A4, A6, and 1A series) derived from cotransfection of the corresponding wild-type 17syn' gB fragment into Fl, viral DNAs from the parent strains and the transfection progeny were cut with Ncol and hybridized to the same 379-bp PCR product described above (Fig. 2) . The syncytial C4 viruses all lost the NcoI site, as would be predicted if they had acquired the gB syn mutation from Fl. In contrast, despite being nonsyncytial, A4B and A61B (Fig. 2) , as well as 1ACSS (data not shown), did not acquire the expected NcoI restriction site from the wild-type gB sequence used in the cotransfections. To confirm these results, we sequenced the PCR products amplified from both nonsyncytial viruses A4B and A61B, as well as from syncytial virus C4A. As expected, the C4A virus contained the single-base Fl syn mutation incorporated into its gB sequence. The sequences from the nonsyncytial A4B and A61B viruses, however, showed no differences from syncytial parent strain Fl. We therefore concluded that these nonsyncytial isolates were derivatives of Fl but had become nonsyncytial because of a spontaneous or transfection-induced (7, 27) mutation(s) elsewhere which suppressed the syncytial phenotype conferred by the gB syn mutation.
Rescue and genetic mapping of the A4B syn suppressor mutation. To genetically map the syn suppressor (SS) mutation in virus A4B, we cloned a library of the EcoRI fragments from strain Fl and utilized these clones as donor fragments in cotransfections performed with unit length DNA from nonsyncytial SS mutant A4B. When we screened the transfection progeny, we found syn plaques (at 20% plete open reading frames (ULM5 to UL51) and portions of UL44 and UL52 (31) .
We next performed a series of cotransfections with subfragments of the Fl EcoRI I fragment. The ability to restore the syncytial phenotype (see frequencies of rescue next to fragments in Fig. 3 ) was mapped first to a 3.5-kb EcoRI-SacI fragment at the left-hand side of EcoRI-I, narrowed to a 1,158-bp XbaI-HindIII fragment, and then mapped to a cloned 797-bp SphI-HindIII fragment containing the UL45 open reading frame and 31 bp of UL46. Finally, we were able to rescue syn suppression by using a cloned 528-bp SphI-RsaI fragment of Fl that contains only UL45. As a control, no syncytial progeny were obtained from cotransfections of A4B unit length DNA with the corresponding cloned SphI-RsaI fragment from A4B itself. Despite several attempts, we were unable to rescue the syn suppression with either the 1,507-bp EcoRI-BamHI fragment or the 721-bp BamHI fragment. These fragments overlap the region where other fragments did rescue the syn suppression (Fig. 3) , a finding which suggested that the syn suppressor mutation might map near the BamHI site within the UL45 gene.
If A4B contained a mutation in its UL45 gene which suppressed the expression of the Fl syncytial phenotype, we hypothesized that the transfer of wild-type UL45 genes to A4B should restore its syncytial phenotype. To determine if this was the case, we used the 797-bp HindIII-SphI fragments containing UL45 cloned from Fl, from 17syn+ (the parent strain of Fl), and as a control, from A4B itself in cotransfections with unit length A4B DNA and screened the progeny for syncytial plaques. Both the Fl and 17syn + fragments, but not the corresponding fragment from A4B, restored the syncytial phenotype. We concluded, then, that the wild-type UL45 gene was capable of restoring the syncytial phenotype to A4B and that the A4B UL45 gene carried the mutation which caused suppression of the syncytial phenotype. Representative syncytial viruses were plaque purified from these backcross trans- fections rescued with either the 17syn+ fragment (Ti series) or the Fl fragment (T9 series). These viruses and their derivations are listed in Table 1 .
Determination of the nucleotide sequence of the mutant UL45 gene of A4B. To precisely define the SS mutation in A4B, we cloned the 797-bp SphI-HindIII fragments from A4B, Fl, ANG (the donor parent strain of Fl), and 17syn+ into M13mpl8 and mpl9 and determined their DNA sequences (Fig. 4A) . The Fl, 17syn+, and ANG sequences were identical within the UL45 open reading frame, except for a singlenucleotide change in ANG that did not affect the deduced amino acid sequence. We found that A4B, on the other hand, had a single-base (C) deletion at nucleotide 230 of the UL45 open reading frame, which would be predicted to result in a frameshift. We believe that the close proximity (3 bp) of this deletion to the BamHI site in UL45 was, as theorized, the reason we were unable to rescue the suppressor mutation with the Fl BamHI fragments. The deduced amino acid sequence of the mutant UL45 protein (Fig. 4B) 
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The UL45 mutation in A4B also suppressed syncytium formation in other gB syn mutants. We next investigated whether the UL45 frameshift mutation in A4B would suppress syncytium formation by gB syn mutant viruses other than Fl. We introduced the UL45 SS mutation into gB syn mutants ANG and C4A by cotransfection with the cloned A4B EcoRI I fragment (for higher recombination efficiencies due to its larger size). The various cotransfections and controls and the frequencies of nonsyncytial progeny are presented in Table 2 .
I-DX 17+ Multiple cotransfections with the A4B EcoRI I fragment into unit length DNAs from Fl, C4A, and ANG all produced 9- Fl typical nonsyncytial plaques at frequencies above the background, although the frequencies were not as high as in the -*---* A4-B converse experiments in which we rescued the UL45 syn suppressor mutation in A4B (Fig. 3) . In the control transfecv o T1A-4A tions with the various unit length viral DNAs alone, we -*--T9B-4B observed 10 nonsyncytial plaques in the C4A transfection, 2 nonsyncytial plaques in the ANG transfection, and no nonsyn-0203040 cytial plaques in the Fl transfection (Table 2 ). Representative We prepared infected-cell lysates from these nonsyncytial isolates and screened them by Western immunoblotting for expression of UL45 (see Fig. 9 ). As expected, consistent with ransfer membranes and buffers, we were unable to the transfer of the A4B UL45 SS mutation, all of the nonsynimmunoreactive protein bands of 18 kDa or smaller cytial viruses (Fl-lA, FI-IB, C4A-1B, C4A-1C, C4A-2D, action from cells infected with A4B.
ANG-1B2, and ANG-2B) isolated from cotransfections of used the Western blot to screen the other indepenparental syn mutant viral DNAs (from Fl, C4A, and ANG, ted mutants in which the syn mutation of Fl was respectively) with the A4B EcoRI I fragment were UL45 (Fig. 6 ). Virus A61B, like A4B, showed no protein negative by Western blot (see Fig. 9 ). Photographs of plaques ctive with the UL45 antiserum. Virus IACSS, on formed by the parental viruses and the progeny of represeniand, produced an immunoreactive protein of the tative cotransfections from this and previously described exbut the intensity of the protein band detected was periments are shown in Fig. 8 . ly lower than that of the band obtained with Fl.
We also characterized UL45 expression in the three sponIts suggested that A61B and IACSS also sustained taneous nonsyncytial revertants which were isolated from the in UL45 resulting, respectively, in either absent or control transfections of ANG or C4A unit length DNA alone. duction of the gene product and in suppression of Alterations were noted in the expression of UL45 by both il phenotype.
nonsyncytial isolates from ANG DNA transfected alone ion of UL45-deficient mutants. Visalli and Brandt (ANG-alone A and B) (Fig. 9) . ANG-alone A (lane 7) )orted that deletion of the UL45 gene from HSV-1 underproduced UL45, and that protein which was present (nonsyncytial) retarded viral replication by approxappeared to migrate more slowly. ANG-alone B (lane 6) fold (44) . To determine whether the mutation in the produced no detectable UL45. In contrast, the nonsyncytial gene and the absence of an immunoreactive UL45 virus isolated from a transfection of C4A DNA alone (lane 12) ct affected its replication, we compared the growth apparently expressed UL45 normally. To rule out the possibilthe relevant viruses in RS cells under one-step ity that spontaneous reversions of the gB syn mutation were (Fig. 7) . All We were initially surprised that we could not isolate nonsyncytial recombinant derivatives of Fl whose gB sequences had been rescued directly through cotransfections with the PCR product containing 379 bp of the wild-type gB gene of 17syn+. Several possibilities might explain this result. One is that the use of a small PCR fragment to rescue the syn mutation in Fl yielded a recombination frequency below a detectable level. This is the most likely hypothesis, since we have recently recovered nonsyncytial derivatives of Fl at a significant frequency by using the much larger EcoRI F fragment of 17syn+ (data not shown). Nonetheless, in three separate cotransfection experiments with the wild-type PCR fragment, all of the nonsyncytial variants of Fl we recovered had alterations in the UL45 gene and not in gB, even though we easily recovered syncytial derivatives of 17syn+ carrying the gB syn mutation in converse experiments with the analogous PCR fragment from Fl. The single nonsyncytial virus studied which was isolated from a transfection of C4A DNA alone (C4A-alone A) retained the original gB syn mutation but also expressed wild-type levels of the UL45 gene product. This virus may well have an undetected mutation that affects its UL45 protein. However, given the complexity of HSV fusion processes, it is also possible that a syn suppressor mutation exists at yet another genetic locus.
Throughout all of the cotransfections we performed, regardless of donor fragment size, the frequency of conferral of the syncytial phenotype to nonsyncytial viruses was always higher than the frequency of restoration of the nonsyncytial phenotype to syncytial viruses. Weise et al. reported obtaining similar results while trying to rescue the gB syncytial mutation in strain ANG (the donor parent of Fl) with fragments from strain KOS (47). Thus, it is possible that the wild-type gB gene, for unknown reasons, exerts adverse effects when expressed in certain viruses, such as ANG and Fl, and therefore is selected against in cotransfections.
The UL45 gene product has been characterized as an 18-kDa protein which is synthesized as a true late gene product and is associated with virions, most likely in the viral envelope (45) . These results support our hypothesis that the UL45 gene product is involved in fusion processes, in that the protein is localized such that it could interact with virion glycoproteins involved in fusion processes. Visalli and Brandt reported that their UL45 null mutant, UL45A, while viable in tissue culture, had reduced replication (44) . This result differs from our finding that UL45 mutant A4B replicated better than its UL45-positive parent and with kinetics similar to those of wild-type HSV. Several possibilities could explain the replicative differences between these two UL45-deficient viruses. First, it is possible that the 4-kB lacZ insertion in UL45A resulted in diminished replicative capabilities through mechanisms unrelated to its deficiency in UL45. These investigators did show that the insertion significantly reduced expression of the gene just upstream, i.e., that for gC. Second, as stated previously, we cannot absolutely rule out the possibility that our UL45 mutant, A4B, makes a truncated UL45 protein which can still carry out some function missing in the UL45 null mutant described by Visalli and Brandt. Third, the UL45 null mutant described by Visalli and Brandt was derived from KOS, a nonsyncytial strain of HSV-1. It is possible that the syncytial mutation still present in gB of Fl somehow compensates for growth and/or fusion deficiencies due to the lack of UL45, thus resulting in wild-type growth of the virus. Finally, HSV syn mutants generally yield reduced viral progeny compared with wild-type viruses and it is possible that elimination of gB-induced cell fusion resulting from the UL45 mutation in A4B removes such a generic impediment to viral replication.
In summary, we have demonstrated that a frameshift mutation in the UL45 gene suppresses the fusogenic properties, but not the in vitro replication, of HSV-1 gB syncytial mutants and that the UL45 gene product can function as an important player in mediating virus-induced cell-cell fusion processes. The UL45 protein may be important in the fusion events that occur normally during infection of cells by HSV-1.
